UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Community Mental Health Care Delivery During the COVID-19 Pandemic: Practical Strategies for Improving Care for People with Serious Mental Illness

Community mental health journal, 2021-04, Vol.57 (3), p.405-415

2021

Volltextzugriff (PDF)

Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

Schizophrenia research, 2011-10, Vol.132 (1), p.50-53

2011

Volltextzugriff (PDF)

Randomized trial of transcranial alternating current stimulation for treatment of auditory hallucinations in schizophrenia

European psychiatry, 2018-06, Vol.51, p.25-33

2018

Volltextzugriff (PDF)

New therapeutic approaches for treatment-resistant schizophrenia: A look to the future

Journal of psychiatric research, 2014-11, Vol.58, p.1-6

2014

Volltextzugriff (PDF)

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles

Nature communications, 2014-09, Vol.5 (1), p.4757-4757, Article 4757

2014

Volltextzugriff (PDF)

Psychometric properties of the Observable Social Cognition Rating Scale (OSCARS): Self-report and informant-rated social cognitive abilities in schizophrenia

Psychiatry research, 2020-04, Vol.286, p.112891-112891, Article 112891

2020

Volltextzugriff (PDF)

A case study of the feasibility of weekly tACS for the treatment of auditory hallucinations in schizophrenia

Brain stimulation, 2021-03, Vol.14 (2), p.361-363

2021

Volltextzugriff (PDF)

Apoptotic mechanisms and the synaptic pathology of schizophrenia

Schizophrenia research, 2006, Vol.81 (1), p.47-63

2006

Volltextzugriff (PDF)

Confidence, performance, and accuracy of self-assessment of social cognition: A comparison of schizophrenia patients and healthy controls

Schizophrenia research. Cognition, 2020-03, Vol.19, p.002-002, Article 100133

2020

Volltextzugriff (PDF)

Apoptotic mechanisms in the pathophysiology of schizophrenia

Progress in neuro-psychopharmacology & biological psychiatry, 2005-06, Vol.29 (5), p.846-858

2005

Volltextzugriff (PDF)

Apoptotic Proteins in the Temporal Cortex in Schizophrenia: High Bax Bcl-2 Ratio Without Caspase-3 Activation

The American journal of psychiatry, 2004-01, Vol.161 (1), p.109-115

2004

Volltextzugriff (PDF)

A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy

Schizophrenia research, 2015-05, Vol.164 (1), p.136-142

2015

Volltextzugriff (PDF)

Targeting reduced neural oscillations in patients with schizophrenia by transcranial alternating current stimulation

NeuroImage (Orlando, Fla.), 2019-02, Vol.186, p.126-136

2019

Volltextzugriff (PDF)

Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression

Schizophrenia research, 2010-05, Vol.118 (1), p.292-299

2010

Volltextzugriff (PDF)

Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial

Schizophrenia research, 2019-02, Vol.204, p.178-182

2019

Volltextzugriff (PDF)

Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations

Current opinion in psychiatry, 2006-05, Vol.19 (3), p.307-312

Jarskog, L Fredrik

2006

Volltextzugriff (PDF)

Depression and reduced emotional experience in schizophrenia: Correlations with self-reported and informant-rated everyday social functioning

Journal of experimental psychopathology, 2019-04, Vol.10 (2), p.204380871982931

2019

Volltextzugriff (PDF)

Oxytocin, Dopamine, and the Amygdala: A Neurofunctional Model of Social Cognitive Deficits in Schizophrenia

Schizophrenia bulletin, 2011-09, Vol.37 (5), p.1077-1087

2011

Volltextzugriff (PDF)

Early cognitive development and psychopathology in children at familial high risk for schizophrenia

Schizophrenia research, 2024-09, Vol.271, p.262-270

2024

Volltextzugriff (PDF)

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study

Neurology, 2017-05, Vol.88 (21), p.2003

2017

Volltextzugriff (PDF)

Autism symptoms, depression, and active social avoidance in schizophrenia: Association with self-reports and informant assessments of everyday functioning

Journal of psychiatric research, 2019-08, Vol.115, p.36-42

2019

Volltextzugriff (PDF)

Neurophysiological substrates of configural face perception in schizotypy

Schizophrenia research, 2020-02, Vol.216, p.389-396

2020

Volltextzugriff (PDF)

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet. Psychiatry, 2017-08, Vol.4 (8), p.595-604

2017

Volltextzugriff (PDF)

The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial

Journal of psychiatric research, 2024-03, Vol.171, p.95-98

2024

Volltextzugriff (PDF)

A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia

Schizophrenia research, 2017-07, Vol.185, p.88-95

2017

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(99)

Sprache

Englisch
(99)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(75)
Psychiatry
(60)
Humans
(57)
Schizophrenia
(56)
Female
(38)
Male
(38)
Adult
(32)
Schizophrenia - Drug Therapy
(26)
Neurosciences & Neurology
(25)
Biological And Medical Sciences
(23)
Middle Aged
(23)
Medical Sciences
(22)
Neurosciences
(22)
Psychology. Psychoanalysis. Psychiatry
(22)
Psychopathology. Psychiatry
(20)
Adult And Adolescent Clinical Studies
(19)
Psychoses
(19)
Antipsychotic Agents - Therapeutic Use
(16)
Adolescent
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Community Mental Health Care Delivery During the COVID-19 Pandemic: Practical Strategies for Improving Care for People with Serious Mental Illness

Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

Randomized trial of transcranial alternating current stimulation for treatment of auditory hallucinations in schizophrenia

New therapeutic approaches for treatment-resistant schizophrenia: A look to the future

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles

Psychometric properties of the Observable Social Cognition Rating Scale (OSCARS): Self-report and informant-rated social cognitive abilities in schizophrenia

A case study of the feasibility of weekly tACS for the treatment of auditory hallucinations in schizophrenia

Apoptotic mechanisms and the synaptic pathology of schizophrenia

Confidence, performance, and accuracy of self-assessment of social cognition: A comparison of schizophrenia patients and healthy controls

Apoptotic mechanisms in the pathophysiology of schizophrenia

Apoptotic Proteins in the Temporal Cortex in Schizophrenia: High Bax Bcl-2 Ratio Without Caspase-3 Activation

A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy

Targeting reduced neural oscillations in patients with schizophrenia by transcranial alternating current stimulation

Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression

Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial

Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations

Depression and reduced emotional experience in schizophrenia: Correlations with self-reported and informant-rated everyday social functioning

Oxytocin, Dopamine, and the Amygdala: A Neurofunctional Model of Social Cognitive Deficits in Schizophrenia

Early cognitive development and psychopathology in children at familial high risk for schizophrenia

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study

Autism symptoms, depression, and active social avoidance in schizophrenia: Association with self-reports and informant assessments of everyday functioning

Neurophysiological substrates of configural face perception in schizotypy

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial

A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia

Suchergebnisse filtern